cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
10x Genomics Inc
18 own
14 watching
Current Price
$26.9
$-0.62
(-2.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
5,104.7M
52-Week High
52-Week High
63.57000
52-Week Low
52-Week Low
26.30000
Average Volume
Average Volume
1.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization5,104.7M
icon52-Week High63.57000
icon52-Week Low26.30000
iconAverage Volume1.04M
iconDividend Yield--
iconP/E Ratio--
What does the 10x Genomics Inc do?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems. The company serves researchers in approximately 40 countries. Its customers include a range of academic, government, biopharmaceutical, biotechnology, and other institutions worldwide. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. The company was incorporated in 2012 and is based in Pleasanton, California.
Read More
How much money does 10x Genomics Inc make?
News & Events about 10x Genomics Inc.
Ticker Report
10 months ago
10x Genomics, Inc. (NASDAQ:TXG Get Rating) CEO Serge Saxonov sold 2,000 shares of the stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $58.16, for a total value of $116,320.00. Following the sale, the chief executive officer now directly owns 891,...
Ticker Report
1 year ago
10x Genomics, Inc. (NASDAQ:TXG Get Rating) CEO Serge Saxonov sold 2,000 shares of the stock in a transaction on Friday, April 14th. The shares were sold at an average price of $53.82, for a total value of $107,640.00. Following the completion of the transaction, the chief executive officer ...
Zolmax
1 year ago
10x Genomics, Inc. (NASDAQ:TXG Get Rating) CEO Serge Saxonov sold 2,000 shares of 10x Genomics stock in a transaction on Friday, April 14th. The shares were sold at an average price of $53.82, for a total value of $107,640.00. Following the completion of the transaction, the chief executive officer ...
Zolmax
1 year ago
Shares of 10x Genomics, Inc. (NASDAQ:TXG Get Rating) have earned a consensus recommendation of Hold from the eleven analysts that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and four ...
Ticker Report
1 year ago
Brinker Capital Investments LLC bought a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG Get Rating) during the second quarter, according to the company in its most recent disclosure with the Securities Exchange Commission. The fund bought 9,262 shares of the companys ...
Frequently Asked Questions
Frequently Asked Questions
What is 10x Genomics Inc share price today?
plus_minus_icon
Can Indians buy 10x Genomics Inc shares?
plus_minus_icon
How can I buy 10x Genomics Inc shares from India?
plus_minus_icon
Can Fractional shares of 10x Genomics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in 10x Genomics Inc stocks?
plus_minus_icon
What is today’s traded volume of 10x Genomics Inc?
plus_minus_icon
What is today’s market capitalisation of 10x Genomics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of 10x Genomics Inc?
plus_minus_icon
What percentage is 10x Genomics Inc down from its 52-Week High?
plus_minus_icon
What percentage is 10x Genomics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$26.9
$-0.62
(-2.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
NATIONAL RESEARCH CORP
NATIONAL RESEARCH CORP
$33.59
$-0.68 (-1.98 %)
agilon health, Inc.
agilon health, Inc.
$5.13
$-0.20 (-3.75 %)
OptimizeRx Corporation
OptimizeRx Corporation
$8.80
$-0.36 (-3.93 %)
DermTech Inc
DermTech Inc
$0.59
$-0.03 (-4.66 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
NATIONAL RESEARCH CORP
NATIONAL RESEARCH CORP
$33.59
$-0.68 (-1.98 %)
agilon health, Inc.
agilon health, Inc.
$5.13
$-0.20 (-3.75 %)
OptimizeRx Corporation
OptimizeRx Corporation
$8.80
$-0.36 (-3.93 %)
DermTech Inc
DermTech Inc
$0.59
$-0.03 (-4.66 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00